Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 3/2008

01-06-2008 | Case Report

Cardiac metastasis from renal cell carcinoma without inferior vena involvement: a review of the literature based on a case report. Two different patterns of spread?

Authors: Fable Zustovich, Fedra Gottardo, Luca De Zorzi, Attilio Cecchetto, Massimo Dal Bianco, Endai Mauro, Giuseppe Cartei

Published in: International Journal of Clinical Oncology | Issue 3/2008

Login to get access
Metadata
Title
Cardiac metastasis from renal cell carcinoma without inferior vena involvement: a review of the literature based on a case report. Two different patterns of spread?
Authors
Fable Zustovich
Fedra Gottardo
Luca De Zorzi
Attilio Cecchetto
Massimo Dal Bianco
Endai Mauro
Giuseppe Cartei
Publication date
01-06-2008
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 3/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0730-6

Other articles of this Issue 3/2008

International Journal of Clinical Oncology 3/2008 Go to the issue

Case Report

Benign multicystic peritoneal mesothelioma in a cesarean-section scar presenting as a fungating mass

Original Article

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)

Original Article

Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1–10.0 ng/ml as a criterion

Original Article

Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan

Introduction to Review Articles

Chemotherapy for gastric cancer in Japan

Review Article

Challenge for a better combination with basic evidence
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits